Cocrystal Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $136 | $0 |
Gross Profit | -21 | -25 | 68 | -30 |
EBITDA | -2,087 | -2,341 | -3,238 | -4,943 |
EBIT | -2,108 | -2,366 | -3,266 | -5,042 |
Net Income | -2,055 | -2,301 | -3,266 | -4,939 |
Net Change In Cash | 0 | 0 | 136 | 0 |
Free Cash Flow | -2,155 | -2,939 | -3,160 | -5,183 |
Cash | 4,766 | 6,921 | 9,860 | 13,020 |
Basic Shares | 10,174 | 10,174 | 10,174 | 10,174 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $5,427 |
Gross Profit | -126 | -15,169 | -241 | -239 |
EBITDA | -17,432 | -19,372 | -17,749 | -13,799 |
EBIT | -17,878 | -17,984 | -18,137 | -14,181 |
Net Income | -17,504 | -17,984 | -38,837 | -14,189 |
Net Change In Cash | 0 | 0 | 0 | 5,427 |
Free Cash Flow | -16,493 | -14,784 | -21,509 | -12,771 |
Cash | 9,860 | 26,353 | 37,144 | 58,705 |
Basic Shares | 10,174 | 9,651 | 8,143 | 7,689 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.20 |
2025-03-31 | -$0.32 |
2024-12-31 | -$0.32 |
2024-09-30 | -$0.49 |
